Durvalumab vs Lorazepam

## Durvalumab vs Lorazepam: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Lorazepam**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Lorazepam**: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Lorazepam — 10-20 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Lorazepam — C15H10Cl2N2O2.

**Molecular Weight**: Durvalumab — N/A; Lorazepam — 321.1580 g/mol.

**Type**: Durvalumab — Antibody; Lorazepam — Small molecule.